EMULATE THERAPEUTICS
Dead / Abandoned — Abandoned — after inter partes decision (as of 14 Feb 2024)
What this means for you
This application is over — abandoned 14 Feb 2024. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 97389517
- Mark type
- Stylized text
- Filed
- 29 Apr 2022
- Published for opposition
- 18 Jul 2023
- Abandoned
- 14 Feb 2024
Goods and services
- Class 010 — Medical apparatus: Medical apparatus for use in treating cancer, pain, inflammation, and solid cancer tumors such as mycosis fungoides, plasma cell tumors, fibrosarcomas, neurofibrosarcomas, schwannomas, malignant melanomas, hermangiopericytomas, hepatic adenocarcinomas, mast cell tumors, mammary adenocarcinomas, osteosarcomas, chondrosarcomas, apocrine glandadenocarcinomas, undifferentiated carcinomas, and transitional cell carcinomas tumors, and mental health conditions, namely, PTSD, depression, anxiety and addiction; Medical device for treating cancer
- Class 042 — Scientific and technological services: Product development in the field of medical device technology; Research and development in the field of medical device technology for use in treating cancer, pain, inflammation, tumors, and a wide range of ailments and disease; Research and development of technology in the field of disease treatment
Owner
- EMulate Therapeutics, Inc., Seattle, WA, US
- EMulate Therapeutics, Inc., Seattle, WA, US
Prosecution history
- 15 Feb 2024 — ABANDONMENT NOTICE E-MAILED - INTER PARTES DECISION
- 14 Feb 2024 — OPPOSITION TERMINATED NO. 999999
- 14 Feb 2024 — OPPOSITION SUSTAINED NO. 999999
- 14 Feb 2024 — ABANDONMENT - AFTER INTER PARTES DECISION
- 15 Nov 2023 — OPPOSITION INSTITUTED NO. 999999
- 11 Aug 2023 — EXTENSION OF TIME TO OPPOSE RECEIVED
- 18 Jul 2023 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 18 Jul 2023 — PUBLISHED FOR OPPOSITION
- 28 Jun 2023 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 14 Jun 2023 — LAW OFFICE PUBLICATION REVIEW COMPLETED
- 07 Jun 2023 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 07 Jun 2023 — EXAMINER'S AMENDMENT ENTERED
- 07 Jun 2023 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 07 Jun 2023 — EXAMINERS AMENDMENT E-MAILED
- 07 Jun 2023 — EXAMINERS AMENDMENT -WRITTEN